![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Nakazato A. Okuyama S.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.10, Iss.1, 2000-01, pp. : 75-98
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antipsychotic drugs: recent developments and novel agents
By Howard H.R.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The therapeutic potential of novel cardiotonic agents
By Endoh Masao
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 5, 2003-05 ,pp. :